Indirect patient expenses for antituberculosis treatment in Tijuana, Mexico: Is treatment really free?

Journal of Infection in Developing Countries

Volumn 3, Issue 10, 2009, Pages 778-782

  Guzmán Montes, Gema Yolanda ^a   Ovalles, Renata Heras ^a   Laniado Laborín, Rafael ^b,c  

^a Hospital General de Tijuana   (Mexico)

^b ISESALUD   (Mexico)

^c UNIVERSIDAD AUTÓNOMA DE BAJA CALIFORNIA   (Mexico)

Author keywords

Costs; Treatment; Tuberculosis; Unaccounted

Indexed keywords

PYRIDOXINE; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TUBERCULOSTATIC AGENT;

ADULT; AGE DISTRIBUTION; ARTICLE; BEVERAGE; CONTROLLED STUDY; COST BENEFIT ANALYSIS; COST OF ILLNESS; DEMOGRAPHY; DIRECTLY OBSERVED THERAPY; DRUG COST; FEMALE; FOOD; HOME CARE; HUMAN; LABORATORY TEST; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MEXICO; QUESTIONNAIRE; RELAPSE; TREATMENT FAILURE; ULTRASOUND;

EID: 73649119862     PISSN: 20366590     EISSN: 19722680     Source Type: Journal    
DOI: 10.3855/jidc.489     Document Type: Article

References (21)

1. Wilkinson D, Floyd K, Gilks CF (1997) Costs and cost-effectiveness of alternative tuberculosis management strategies in South Africa - implications for policy. S Afr Med J 87: 451-455.
2. Rubel AJ and Garro LC (1992) Social and Cultural Factors in the Successful Control of Tuberculosis. Public Health Reports 107: 626-636.
3. Needham D M, Godfrey-Faussett P, Foster S D (1998) Barriers to tuberculosis control in urban Zambia: the economic impact and burden on patients prior to diagnosis. Int J Tuberc Lung Dis 2: 811-817.
4. Floyd K (2003) Costs and effectiveness - the impacts of economic studies on TB control. Tuberculosis 83: 187-200.
5. Floyd K, Skeva J, Nyirenda T, Gausi F, Salaniponi F (2003) Cost and cost-effectiveness of increased community and primary care facility involvement in tuberculosis care in Lilongwe District, Malawi. Int J Tuberc Lung Dis 7 (Suppl 1): S29-S37.
6. Fryatt R J (1997) Review of published cost-effectiveness studies on tuberculosis treatment programmes. Int J Tuberc Lung Dis 1: 101-109.
7. Nganda B, Wangombe J, Floyd K, Kangangi J (2003) Cost and cost effectiveness of increased community and primary care facility involvement in tuberculosis care in Machakos District, Kenya. Int J Tuberc Lung Dis 7 (Suppl 1): S14-S20.
8. Okello D, Floyd K, Adatu F, Odeke R, Gargioni G (2003) Cost and cost-effectiveness of community-based care for tuberculosis patients in rural Uganda. Int J Tuberc Lung Dis 7 (Suppl 1): S72-S79.
9. Sinanovic E, Floyd K, Dudley L, Azevedo V, Grant R, Maher D (2003) Cost and cost-effectiveness of community-based care for tuberculosis in Cape Town, South Africa. Int J Tuberc Lung Dis 7 (Suppl 1): S56-S62.
10. Sanou A, Dembele M, Theobald S, Macq J (2004) Access and adhering to tuberculosis treatment: Barriers faced by patients and communities in Burkina Faso. Int J Tuberc Lung Dis 8: 1479-1483.
11. Johansson E, Winkvist A (2002) Trust and transparency in human encounters in tuberculosis control: Lessons learned from Vietnam. Qual Health Res 12: 473-491.
12. Khan A, Walley J, Newell J, Imdad N (2000) Tuberculosis in Pakistan: Sociocultural constraints and opportunities in treatment. Soc Sci Med 50: 247-254.
13. Johansson E, Diwan VK, Huong ND, Ahlberg BM (1996) Staff and patient attitudes to tuberculosis and compliance with treatment and exploratory study in a district in Vietnam. Tuber Lung Dis 77: 178-183.
14. Munro SA, Lewin SA, Smith H, Engel ME, Fretheim A, Volmink J (2007) Patient adherence to tuberculosis treatment: A systematic review of qualitative research. PLoS Med 4:e238. doi:10.1371/journal.pmed.0040238.
15. Khan MA, Walley JD, Witter SN, Shah SK, Javeed S (2005) Tuberculosis patient adherence to direct observation: Results of a social study in Pakistan. Health Policy Plan 20: 354-365.
16. Jaiswal A, Singh V, Ogden JA, Porter JDH, Sharma PP, Sarin R, Arora VK, Jain RC (2003) Adherence to tuberculosis treatment: Lessons from the urban setting of Delhi, India. Trop Med Int Health 8: 625-633.
17. Johansson E, Long NH, Diwan VK, Winkvist A (1999) Attitudes to compliance with tuberculosis treatment among women and men in Vietnam. Int J Tuberc Lung Dis 3: 862-868.
18. Harper M, Ahmadu FA, Ogden JA, McAdam KP, Lienhardt C (2003) Identifying the determinants of tuberculosis control in resource-poor countries: Insights from a qualitative study in The Gambia. Trans R Soc Trop Med Hyg 97: 506-510.
19. Nair D, George A, Chacko K (1997) Tuberculosis in Bombay: New insights from poor urban patients. Health Policy Plan 12: 77-85.
20. Liefooghe R, Michiels N, Habib S, Moran MB, de Muynck A (1995) Perception and social consequences of tuberculosis: A focus group study of tuberculosis patients in Sialkot, Pakistan. Soc Sci Med 41: 1685-1692.
21. Aspler A, Menzies D, Oxlade O, Banda J, Mwenge L, Godfrey-Faussett P, Ayles H (2008) Cost of tuberculosis diagnosis and treatment from the patient perspective in Lusaka, Zambia. Int J Tuberc Lung Dis 12:928-935.